Back to top
more

Franklin Strategic Biotechnology: (MF: FBDIX)

(MF) As of Dec 8, 2016 06:05 PM ET

 Add to portfolio

$138.43 USD

+0.25 (0.18%)

Zacks MF Rank [?]: 5-Strong Sell         5

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Latest Performance as of Oct 31, 2016

Total Return %* Percentile Rank Objective
YTD -21.35 89
3 months -7.08 11
6 months 0.35 9
1 Year -18.42 89
3 Year 7.02 66
5 Year 20.19 10
10 Year 11.94 15

* Annual for three years and beyond.

Zacks Premium Research for FBDIX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Strong Sell 5
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 35.61
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 10/31/2016 1,209.91
%Turnover 10/31/2016 22.13

Risk

3 Year 5 Year 10 Year
Beta 1.39 1.34 0.86
Alpha -1.95 3.85 7.13
R Squared 0.30 0.32 0.36
Std. Dev. 27.17 24.27 21.96
Sharpe 0.40 0.97 2.00

Sector / Country Weightings

As of 10/31/2016 % of Portfolio
Health 60.71
Services 16.95
Other 10.45
Industrial Cyclical 8.39
Technology 2.54
Retail Trade 0.96

Portfolio Holdings

Top Equity Holdings
(As of 7/31/2016)
% of Portfolio Value (Mil$)
CELGENE CORP 9.77 129.38
BIOGEN IDEC INC 7.73 102.36
GILEAD SCIENCES INC 6.75 89.34
AMGEN INC 6.03 79.87
INCYTE PHARMACEUTICALS IN 4.15 55.02
MEDIVATION INC 4.10 54.27
REGENERON PHARMACEUTICALS 3.63 48.13
VERTEX PHARMACEUTICALS IN 3.27 43.30
BIOMARIN PHARMACEUTICAL 3.08 40.79

Stock Holding % of Net Assets

As Of 7/31/2016
Total Issues 112
Avg. P/E 45.44
Avg. P/Book 5.91
Avg. EPS Growth 15.5
Avg. Market Value (Mil $) 39,451

Allocation

% of Portfolio
Large Growth 30.25
Large Value 0.00
Small Growth 20.03
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 0.00